Security Snapshot

Fresenius Medical Care AG - Ordinary Shares without par value (FMS) Institutional Ownership

CUSIP: 358029106

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

232

Shares (Excl. Options)

42,479,559

Price

$22.61

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+668,698
Value change
+$15,218,149
Number of holders
232
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
292,938,399
SEC-reported price per share
$24.59
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • FMS - Fresenius Medical Care AG - Ordinary Shares without par value is tracked under CUSIP 358029106.
  • 232 institutions reported positions in Q2 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 218 to 232 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $949,964,344 to $960,512,242.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 232 institutions filings for Q2 2026.

Open SEC evidence

Security key

358029106

Latest holder period

Q2 2026

13F holders

232

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
FMS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fresenius SE & Co. KGaA 29% -11% $2,024,971,833 -$256,202,000 83,780,382 -11% Fresenius SE & Co. KGaA 06 Mar 2025
HARRIS ASSOCIATES L P 3.9% $283,213,788 11,717,575 HARRIS ASSOCIATES L P 31 Dec 2024

As of 30 Jun 2026, 232 institutional investors reported holding 42,479,559 shares of Fresenius Medical Care AG - Ordinary Shares without par value (FMS). This represents 15% of the company’s total 292,938,399 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
13%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
PZENA INVESTMENT MANAGEMENT LLC 5.1% 14,992,081 -0.4% 1% $338,970,952
MORGAN STANLEY 1.5% 4,347,748 +75% 0.01% $98,302,636
Dodge & Cox 1.3% 3,826,910 0% 0.05% $86,526,435
FIDUCIARY MANAGEMENT INC /WI/ 1% 2,937,829 -34% 0.94% $66,424,314
BRANDES INVESTMENT PARTNERS, LP 0.65% 1,916,090 +19% 0.3% $43,323,176
MILLENNIUM MANAGEMENT LLC 0.54% 1,571,805 -4.2% 0.02% $35,538,511
TODD ASSET MANAGEMENT LLC 0.45% 1,305,386 +0.68% 0.52% $29,514,940
GOLDMAN SACHS GROUP INC 0.31% 898,668 +9.9% 0% $20,318,888
BlackRock, Inc. 0.29% 860,302 +37% 0% $19,451,429
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 0.28% 816,200 0% 0.13% $18,454,000
Quantinno Capital Management LP 0.18% 527,966 +55% 0.01% $11,937,327
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 0.16% 465,587 +126% 0.05% $10,526,922
ENVESTNET ASSET MANAGEMENT INC 0.15% 428,696 +12% 0% $9,692,471
NORTHERN TRUST CORP 0.13% 384,960 +1.4% 0% $8,703,946
WELLS FARGO & COMPANY/MN 0.13% 381,361 +14% 0% $8,622,583
RAYMOND JAMES FINANCIAL INC 0.12% 364,770 -14% 0% $8,247,454
Moran Wealth Management, LLC 0.12% 362,438 +4.2% 0.22% $8,194,724
Creative Planning 0.1% 297,333 +62% 0% $6,722,694
ROYAL BANK OF CANADA 0.09% 262,795 +21% 0% $5,942,000
FMR LLC 0.08% 245,682 -17% 0% $5,554,864
ABC ARBITRAGE SA 0.08% 239,751 0.59% $5,420,770
JPMORGAN CHASE & CO 0.08% 222,165 +91% 0% $5,043,147
UBS Group AG 0.08% 219,748 +94% 0% $4,968,502
D. E. Shaw & Co., Inc. 0.07% 210,747 -51% 0% $4,764,990
HRT FINANCIAL LP 0.07% 205,722 +140% 0.01% $4,651,000

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 42,479,559 $960,512,242 +$15,218,149 $22.61 232
2026 Q1 42,110,766 $949,964,344 +$95,371,958 $22.56 218
2025 Q4 37,508,073 $893,440,267 +$33,309,792 $23.82 213
2025 Q3 36,120,634 $951,005,129 -$14,569,100 $26.33 203
2025 Q2 36,636,431 $1,046,674,202 +$46,295,068 $28.57 203
2025 Q1 35,046,889 $872,643,678 +$27,257,295 $24.90 197
2024 Q4 34,017,350 $770,139,012 +$5,191,746 $22.64 187
2024 Q3 33,465,497 $713,210,489 +$46,953,355 $21.30 164
2024 Q2 31,332,670 $598,145,446 -$36,538,124 $19.09 166
2024 Q1 33,213,535 $640,484,181 -$410,800 $19.28 168
2023 Q4 33,129,394 $689,882,206 -$1,429,220 $20.83 160
2023 Q3 33,054,027 $711,494,307 -$24,576,102 $21.54 146
2023 Q2 34,074,546 $815,697,393 -$113,386,403 $23.93 141
2023 Q1 38,943,140 $828,079,836 -$106,128,012 $21.26 147
2022 Q4 44,147,684 $721,518,359 +$190,854,706 $16.34 151
2022 Q3 32,612,977 $457,762,115 -$40,450,898 $14.04 133
2022 Q2 32,237,246 $803,829,195 +$52,339,396 $24.94 155
2022 Q1 30,584,664 $1,030,101,462 +$97,919,185 $33.68 173
2021 Q4 27,697,563 $899,187,170 +$54,237,214 $32.46 165
2021 Q3 25,876,821 $905,133,412 +$190,668,853 $34.97 150
2021 Q2 20,356,867 $846,033,789 +$44,454,274 $41.57 168
2021 Q1 19,343,763 $713,592,444 +$321,140,390 $36.88 162
2020 Q4 10,477,415 $435,514,087 +$61,869,042 $41.56 169
2020 Q3 9,057,592 $384,729,746 +$298,263 $42.48 175
2020 Q2 9,267,915 $401,447,759 +$17,538,666 $43.28 170
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .